Good observation groins, and solanezumab is not a BACE inhibitor. The BACE inhibitor trial they stopped due to liver side effects was for LY2886721
http://www.fiercebiotech.com/story/eli-lilly-racks-another-alzheimers-failure-after-bace-drug-sparks-safety-fe/2013-06-13
the past, present and future of alzheimer’s..., page-3
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $2.564K | 854.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 61 | 80531900 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 2803048 | 3 |
View Market Depth
| Last trade - 10.19am 18/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |